The rapid development of COVID vaccines marked a historic achievement, reducing the typical timeline from ten years to less than one. With a remarkable 95% reduction in symptomatic infections, these vaccines not only showcased unprecedented speed but also extraordinary efficacy against emerging variants. This success is rooted in decades of research and perseverance in mRNA technology, culminating in a significant advancement in public health.
